Assessing The Biological Weapons And Bioterrorism Threat

It is nearly 15 years since biological weapons (BW) have become a significant national security preoccupation. The events of September 11, 2001, although not in any way related to BW, combined with the distribution of professionally prepared anthrax spores through the U.S. postal system in the weeks afterwards, magnified previous concerns by orders of magnitude.

It is nearly 15 years since biological weapons (BW) have become a significant national security preoccupation. The events of September 11, 2001, although not in any way related to BW, combined with the distribution of professionally prepared anthrax spores through the U.S. postal system in the weeks afterwards, magnified previous concerns by orders of magnitude.

In the wake of September 11th and recent anthrax events, our nation's bioterrorism response capability has become an imminent priority for policymakers, researchers, public health officials, academia, and the private sector. In a three-day workshop, convened by the Institute of Medicine's Forum on Emerging Infections, experts from each of these communities came together to identify, clarify, and prioritize the next steps that need to be taken in order to prepare and strengthen bioterrorism response capabilities. From the discussions, it became clear that of utmost urgency is the need to cast the issue of a response in an appropriate framework in order to attract the attention of Congress and the public in order to garner sufficient and sustainable support for such initiatives. No matter how the issue is cast, numerous workshop participants agreed that there are many gaps in the public health infrastructure and countermeasure capabilities that must be prioritized and addressed in order to assure a rapid and effective response to another bioterrorist attack.

?Bioterrorism should appeal to a wide range of academics and practitioners around the world?and it should be required reading in the Executive and Legislative branches of the US government.??Dean A. Wilkening, Stanford UniversityEspecially since the anthrax attacks of 2001, the issue of bioterrorism has been controversial: Are governments underestimating the potential hazard of biological toxins, as some claim, or is the danger in fact exaggerated? What are the policy options for dealing with such a complex threat? The authors of this book offer a reasoned assessment of the issues at the core of the debates.Identifying a high level of uncertainty as a key characteristic of the bioterrorism threat, the authors examine the legacies of the secret state biowarfare programs of the previous century, analyze academic and political controversies about current dangers, and consider the impact of rapid scientific and technological change on the development of future threats. In the process, they provide new insight into the broader question of risk management and the role of public and private actors in international security relations.Andreas Wenger is professor of international security policy and director of the Center for Security Studies at ETH Zurich (the Swiss Federal Institute of Technology). Reto Wollenmann is policy adviser on arms control and disarmament in the Directorate for Security Policy of the Federal Department of Defense.Contents: Foreword?R. Danzig. Bioterrorism: A Complex Threat?the Editors. Understanding the Threat: Actors and Capabilities. The Legacy of Secret State Programs?J. Guillemin. Evolution of the Current Threat?M. Leitenberg. The Impact of Scientific and Technological Change?M. Dando. Assessing the Threat: Differing Perceptions. Knowledge Gaps and Threat Assessments?P.R. Lavoy. Why Do Conclusions From the Experts Vary??M.I. Chevrier. Managing the Threat: Policy Options. When to ?Cry Wolf,? What to Cry, and How to Cry It?A.H. Cordesman. More Transparency for a Secure Biodefense?I. Hunger. Conclusion. Securing Society Against the Risk of Bioterrorism?A. Wenger.

Presents a means of assessing the relative threat from terrorist-use of individual chemical, biological, and toxin agents. It focuses on small-scale, targeted C/B attacks, rather than mass-casualty attacks. The framework considers the elements of access, public health impact, medical treatment, prophylaxis, and dissemination. Other factors that may affect potential use by terrorists include the range of lethality, covert employment of an agent, and the availability of dual-use technol. Contents: Intro.; Background: Definition of C/B Terrorism; Probability of a C/B Weapon Attack; Historical Acquisition and Use of C/B Agents; C/B Assessments; Agent Analysis; Terrorist Motivation-Specific Factors; Policy Issues; Conclusions. Illus. This is a print on demand report.

This book summarises the lectures presented at the Centre of Excellence - Defence Against Terrorism (COE-DAT) workshop on Bioterrorism of November 2008. The contributors are a diverse group of academics and practitioners, selected for their expertise in the field. Their contributions cover the definition and classification of bioterrorism and take account of its various dimensions, examining the theoretical, historical and practical aspects, as well as the defence against it. Consisting of seven papers and four summaries, the book covers subjects such as biodiversity, the historical use of biological agents and the concern for public safety, the role of the International Science & Technology Center in countering bioterrorism, the Global Forum on Biorisks, threat assessment, animal health and disease with reference to biological safety and the Biological Weapons Convention. The workshop itself was of necessity restricted to a small number of participants, but with this book, research, experience and perspectives on biological risks can be shared with a wider audience, allowing further consideration and improvements in countering risks and responding to biological threats and attacks. Inaugurated in 2005, COE-DAT is a NATO accredited Centre of Excellence; a unique centre dedicated to Defence Against Terrorism, which provides DAT training and education at strategic and operational levels and contributes to research efforts. IOS Press is an international science, technical and medical publisher of high-quality books for academics, scientists, and professionals in all fields. Some of the areas we publish in: -Biomedicine -Oncology -Artificial intelligence -Databases and information systems -Maritime engineering -Nanotechnology -Geoengineering -All aspects of physics -E-governance -E-commerce -The knowledge economy -Urban studies -Arms control -Understanding and responding to terrorism -Medical informatics -Computer Sciences